Trial intelligence / Profile preview

Prednisone with or without Liushen Pill for recurrence of subacute thyroiditis

ChiCTR1900025283Phase 4Recruiting

Sponsor
Shanghai Tenth People's Hospital
Start
Oct 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of prednisone and liushenwan in nonsuppurative thyroiditis (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Recurrence rate. Started Oct 2018; status: recruiting.

02

Drugs

prednisoneliushenwan
03

Conditions

nonsuppurative thyroiditis

Beyond the preview

Go deeper on ChiCTR1900025283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900025283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call